News
Early Use of Drug Might Slow Multiple Sclerosis Progression - ABC News
abcnews.go.com
New research from the American Academy of Neurology found that patients given the MS drug interferon beta-1a soon after the first signs of the disease were...
Langzeitstudie überprüft Interferon | PZ – Pharmazeutische Zeitung
www.pharmazeutische-zeitung.de
... dieser Studie bestätigen das bekannte Sicherheits- und Verträglichkeitsprofil von Betaferon«, erklärte der leitende Studienarzt Dr. Anthony T. Reder, Professor ...
Dr. Anthony Reder Managed a Clinical Trial Site for ...
www.newswise.com
Dr. Anthony Reder Managed a Clinical Trial Site for Ocrelizumab, Newly Approved Breakthrough Multiple Sclerosis Drug. Released: ...
Confronting Multiple Sclerosis - Genentech
www.gene.com
When MS expert and neurologist Anthony Reder was a medical resident in Minneapolis in 1982, he remembers there were at least three ...
sorted by relevance / date